Hydroxychloroquine and ivermectin are two drugs that have been around for a long time and therefore have been thoroughly vetted. They are effective, relatively low cost, and highly efficacious. They have proven to be effective in preventing and/or ameliorating more severe symptoms of the coronavirus. Ivermectin is also an effective malaria deterrent and is widely used in Africa for just that reason. (Africa has 12.5 percent of the world’s population but has suffered less than 5 percent of the world’s coronavirus fatalities. Coincidence?)
Yet, our political leaders and “health
experts,” in conjunction with Big Pharma, Big Tech and Big Media, all tell us
that not only shouldn’t we use these wonder drugs, but we can’t even talk about
them in a positive light. Or talk about them at all. Because COVID-19
vaccines are the way, the truth, and the light. Period. So help us
Ergo, when new research from George Washington University determined that treating COVID patients with aspirin reduced the risk of severe illness by nearly half, I knew that it was only a matter of time until anti-aspirin articles and rhetoric started appearing. Turns out, it was only a matter of hours. Despite the fact that health experts have been touting the benefits of an aspirin a day for many years now.
George Washington University’s report noted that an aspirin regimen, in more than 400 COVID-19 patients in hospitals across the United States, cut the need for ventilation by 44%, slashed ICU admission by 43%, and reduced overall in-hospital mortality rates by 47%.
Dr. Jonathan Chow, one of the study's researchers, said: "As we learned about the connection between blood clots and COVID-19, we knew that aspirin — used to prevent stroke and heart attack — could be important for COVID-19 patients. Our research found an association between low-dose aspirin and decreased severity of COVID-19 and death."
Pfizer and companies aren’t going to like that report. So, add aspirin (notice the generic description) to the list of treatments you are not supposed to use to combat the China Virus. Even though it, like vitamin D and almost everything else but the vaccines, appears to be effective in fending off the Wuhan Flu.
So, predictably, a U.S. “expert panel” is now recommending against older adults taking low-dose aspirin. The panel didn’t mention the coronavirus or the pandemic, only that, suddenly and for the first time, their studies show that a daily aspirin regimen doesn’t really prevent heart attacks.
The “U.S. Preventive Services Task Force” said, in a recent draft recommendation statement, that initiating aspirin use for the primary prevention of a first heart attack or stroke in adults aged 60 years or older has no net benefit. The panel noted that aspirin use by older adults increases the risk of potentially life-threatening internal bleeding and outweighs the benefits. That’s funny. The very folks that many-- if not most-- doctors have for decades claimed would benefit most from aspirin are those now being told by the USPSTF not to take it. And those 60 and over are also the ones at a much higher risk for coronavirus complications than younger folks. Hmmm.
The plot thickens. Much like one’s blood after acquiescing to take the Johnson and Johnson jab or the Pfizer prick.
What's really going on here?